S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Bristol-Myers Squibb (BMY) SEC Filings & 10K Form

$48.30
+0.46 (+0.96%)
(As of 04/18/2024 ET)

Recent Bristol-Myers Squibb SEC Filings

DateFilerForm TypeView
04/02/2024
5:37 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:38 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:40 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:41 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:43 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:44 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:45 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
4:16 PM
Bristol-Myers Squibb (Filer)
Form DEF 14A
03/28/2024
4:17 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
03/28/2024
4:19 PM
Bristol-Myers Squibb (Filer)
Form ARS
03/18/2024
4:21 PM
Bristol-Myers Squibb (Filer)
Form PRE 14A
03/18/2024
4:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
7:56 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
8:54 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:43 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:21 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:11 PM
Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:40 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:31 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:58 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:00 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:01 PM
Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:46 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:50 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:43 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:45 PM
Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:52 PM
Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
5:03 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/16/2024
3:34 PM
Bristol-Myers Squibb (Filer)
Form 424B5
02/16/2024
10:36 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/14/2024
8:07 PM
Bristol-Myers Squibb (Subject)
Form FWP
02/13/2024
10:54 AM
Bristol-Myers Squibb (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2024
7:00 AM
Bristol-Myers Squibb (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/12/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/05/2024
6:29 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:31 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:33 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:10 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:13 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
02/05/2024
6:15 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:17 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:21 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:24 PM
Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:26 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:27 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:46 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
7:13 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T
01/08/2024
9:29 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:48 PM
Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2024
4:38 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:39 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:41 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:44 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:31 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:33 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:36 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
3:22 PM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-C
12/22/2023
3:36 PM
Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
Form DFAN14A
12/22/2023
3:21 PM
Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
Form DFAN14A
12/20/2023
5:08 PM
Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
5:06 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:21 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:22 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:23 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:32 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:38 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
6:01 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:30 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
3:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K/A
10/30/2023
4:26 PM
Bristol-Myers Squibb (Subject)
Form FWP
10/30/2023
7:05 AM
Bristol-Myers Squibb (Filer)
Form 424B3
10/26/2023
11:33 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
6:44 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
6:13 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
5:48 AM
Bristol-Myers Squibb (Filed by)
Mirati Therapeutics, Inc. (Subject)
Form DFAN14A
10/04/2023
8:01 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
8:04 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:29 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:31 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:33 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:34 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:36 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:38 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:26 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
4:28 PM
Bristol-Myers Squibb (Issuer)
Powell Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
1:17 PM
Bristol-Myers Squibb (Subject)
Powell Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
6:10 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
4:24 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
08/03/2023
2:54 PM
Bristol-Myers Squibb (Subject)
Plenge Robert M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/27/2023
6:50 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
8:34 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/05/2023
4:31 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:33 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:34 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:35 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:37 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:23 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:BMY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners